Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel M Williams

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Molecular Psychiatry|March 3, 2023
Rare coding variants as risk modifiers of the 22q11.2 deletion implicate postnatal cortical development in syndromic schizophreniaJhih-Rong Lin, Yingjie Zhao, M Reza Jabalameli, et al.
Human Molecular Genetics|November 1, 2016
Additional rare variant analysis in Parkinson's disease cases with and without known pathogenic mutations: evidence for oligogenic inheritanceSteven J Lubbe, Valentina Escott-Price, J Raphael Gibbs, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 8, 2012
Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's diseaseLaura L Kilarski, Justin P Pearson, Victoria Newsway, et al.
Human Molecular Genetics|December 11, 2012
A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's diseasePeter Holmans, Valentina Moskvina, Lesley Jones, et al.
JAMA Neurology|August 8, 2013
Analysis of genome-wide association studies of Alzheimer disease and of Parkinson disease to determine if these 2 diseases share a common genetic riskValentina Moskvina, Denise Harold, GianCarlo Russo, et al.
Neurology|May 13, 2018
Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2Erik Boot, Nancy J Butcher, Sean Udow, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 28, 2020
Genome-Wide Association Studies of Cognitive and Motor Progression in Parkinson's DiseaseManuela M X Tan, Michael A Lawton, Edwin Jabbari, et al.
Nature Neuroscience|April 5, 2022
Exome sequencing of individuals with Huntington's disease implicates FAN1 nuclease activity in slowing CAG expansion and disease onsetBranduff McAllister, Jasmine Donaldson, Caroline S Binda, et al.
Neurobiology of Aging|September 3, 2020
Analysis of DNM3 and VAMP4 as genetic modifiers of LRRK2 Parkinson's diseaseEmmeline E Brown, Cornelis Blauwendraat, Joanne Trinh, et al.
JAMA Neurology|December 21, 2019
Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal SyndromeEdwin Jabbari, Negin Holland, Viorica Chelban, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Molecular Psychiatry|March 3, 2023
Rare coding variants as risk modifiers of the 22q11.2 deletion implicate postnatal cortical development in syndromic schizophreniaJhih-Rong Lin, Yingjie Zhao, M Reza Jabalameli, et al.
Human Molecular Genetics|November 1, 2016
Additional rare variant analysis in Parkinson's disease cases with and without known pathogenic mutations: evidence for oligogenic inheritanceSteven J Lubbe, Valentina Escott-Price, J Raphael Gibbs, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 8, 2012
Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's diseaseLaura L Kilarski, Justin P Pearson, Victoria Newsway, et al.
Human Molecular Genetics|December 11, 2012
A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's diseasePeter Holmans, Valentina Moskvina, Lesley Jones, et al.
JAMA Neurology|August 8, 2013
Analysis of genome-wide association studies of Alzheimer disease and of Parkinson disease to determine if these 2 diseases share a common genetic riskValentina Moskvina, Denise Harold, GianCarlo Russo, et al.
Neurology|May 13, 2018
Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2Erik Boot, Nancy J Butcher, Sean Udow, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 28, 2020
Genome-Wide Association Studies of Cognitive and Motor Progression in Parkinson's DiseaseManuela M X Tan, Michael A Lawton, Edwin Jabbari, et al.
Nature Neuroscience|April 5, 2022
Exome sequencing of individuals with Huntington's disease implicates FAN1 nuclease activity in slowing CAG expansion and disease onsetBranduff McAllister, Jasmine Donaldson, Caroline S Binda, et al.
Neurobiology of Aging|September 3, 2020
Analysis of DNM3 and VAMP4 as genetic modifiers of LRRK2 Parkinson's diseaseEmmeline E Brown, Cornelis Blauwendraat, Joanne Trinh, et al.
JAMA Neurology|December 21, 2019
Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal SyndromeEdwin Jabbari, Negin Holland, Viorica Chelban, et al.
Pageof 9